Roman Michael F — SEC insider filings
SEC reporting owner CIK 1577544. 47 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2021-02-03 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 44 legs across 5 filings — 117,962 shares, $17,942,957 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 58.
- Largest priced transaction: sale of 29,670 shares @ $152.27 ($4,517,851) in 3M CO, filed 2025-01-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| 3M CO (MMM) | Chairman of the Board, Director | 16 | — | 44 legs · 117,962 sh · $17,942,957 | 27 |
| ABBOTT LABORATORIES (ABT) | Director | 28 | — | — | 28 |
| Waystar Holding Corp. (WAY) | Director | 3 | — | — | 3 |
Insider filings — Roman Michael F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 381 (derivative) @ $98.83 | EDGAR |
| 2026-09-25 | 4/A | Waystar Holding Corp. (WAY) | Grant/award (A): 10,446 @ $0 | EDGAR |
| 2026-07-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 416 (derivative) @ $90.74 | EDGAR |
| 2026-06-03 | 4 | Waystar Holding Corp. (WAY) | Grant/award (A): 9,303 @ $0 | EDGAR |
| 2026-04-28 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 2,286 @ $0 | EDGAR |
| 2026-04-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 367 (derivative) @ $102.67 | EDGAR |
| 2026-01-05 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 301 (derivative) @ $125.29 | EDGAR |
| 2025-10-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 281 (derivative) @ $133.94 | EDGAR |
| 2025-07-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 271 (derivative) @ $136.01 | EDGAR |
| 2025-06-16 | 4 | Waystar Holding Corp. (WAY) | Grant/award (A): 5,134 @ $0 | EDGAR |
| 2025-04-29 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,635 @ $0 | EDGAR |
| 2025-04-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 265 (derivative) @ $132.65 | EDGAR |
| 2025-02-18 | 4/A | 3M CO (MMM) | Tax withholding (F): 8,600 @ $0 | EDGAR |
| 2025-02-05 | 4 | 3M CO (MMM) | Grant/award (A): 21,026.99 @ $0 · Tax withholding (F): 9,589 @ $0 | EDGAR |
| 2025-01-30 | 4 | 3M CO (MMM) | Option exercise (M): 54,775 @ $130.14 · Sale (S): 1,326 @ $152.26 · Sale (S): 29,670 @ $152.27 · Sale (S): 1,955 @ $152.28 · Sale (S): 372 @ $152.29 · Sale (S): 687 @ $152.30 · +23 more | EDGAR |
| 2025-01-27 | 4 | 3M CO (MMM) | Option exercise (M): 45,276 @ $146.05 · Sale (S): 25,403 @ $150 · Sale (S): 100 @ $150.00 · Sale (S): 8,321 @ $150.01 · Sale (S): 947 @ $150.02 · Sale (S): 200 @ $150.03 · +7 more | EDGAR |
| 2025-01-03 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 311 (derivative) @ $113.11 | EDGAR |
| 2024-10-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 309 (derivative) @ $114.01 | EDGAR |
| 2024-08-08 | 4 | 3M CO (MMM) | Sale (S): 4,139 @ $123.45 · Sale (S): 611 @ $123.46 · Sale (S): 443 @ $123.47 · Sale (S): 482 @ $123.48 | EDGAR |
| 2024-07-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 339 (derivative) @ $103.91 | EDGAR |
| 2024-05-06 | 4 | 3M CO (MMM) | Grant/award (A): 316,644 (derivative) @ $97.10 | EDGAR |
| 2024-04-30 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,866 @ $0 | EDGAR |
| 2024-04-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 310 (derivative) @ $113.66 | EDGAR |
| 2024-02-15 | 4/A | 3M CO (MMM) | Tax withholding (F): 791.40 @ $0 | EDGAR |
| 2024-02-06 | 4 | 3M CO (MMM) | Grant/award (A): 24,954.27 @ $0 · Tax withholding (F): 601 @ $0 | EDGAR |
| 2024-01-03 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 320 (derivative) @ $110.07 | EDGAR |
| 2023-10-03 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 363 (derivative) @ $96.85 | EDGAR |
| 2023-07-05 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 316 (derivative) @ $109.02 | EDGAR |
| 2023-05-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,816 @ $0 | EDGAR |
| 2023-04-04 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 325 (derivative) @ $101.26 | EDGAR |
| 2023-02-21 | 4/A | 3M CO (MMM) | Tax withholding (F): 1,140.00 @ $0 | EDGAR |
| 2023-02-08 | 4 | 3M CO (MMM) | Grant/award (A): 35,281.35 @ $0 · Tax withholding (F): 844.74 @ $0 · Grant/award (A): 269,995 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 300 (derivative) @ $109.79 | EDGAR |
| 2022-10-04 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 341 (derivative) @ $96.76 | EDGAR |
| 2022-07-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 303 (derivative) @ $108.65 | EDGAR |
| 2022-05-04 | 4 | 3M CO (MMM) | Option exercise (M): 10,610 @ $101.49 · Sale (S): 10,610 @ $146.21 · Option exercise (M): 10,610 (derivative) @ $0 | EDGAR |
| 2022-05-03 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,602 @ $0 | EDGAR |
| 2022-04-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 278 (derivative) @ $118.36 | EDGAR |
| 2022-02-22 | 4/A | 3M CO (MMM) | Tax withholding (F): 754.04 @ $0 | EDGAR |
| 2022-02-09 | 4 | 3M CO (MMM) | Grant/award (A): 23,427.52 @ $0 · Tax withholding (F): 558.86 @ $0 · Grant/award (A): 217,083 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 234 (derivative) @ $140.74 | EDGAR |
| 2021-10-04 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 279 (derivative) @ $118.13 | EDGAR |
| 2021-07-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 189 (derivative) @ $115.93 | EDGAR |
| 2021-05-04 | 4 | 3M CO (MMM) | Option exercise (M): 9,747 @ $87.89 · Sale (S): 6,803 @ $197.79 · Option exercise (M): 9,747 (derivative) @ $0 | EDGAR |
| 2021-04-27 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,499 @ $0 | EDGAR |
| 2021-02-16 | 4/A | 3M CO (MMM) | Tax withholding (F): 463.67 @ $0 | EDGAR |
| 2021-02-03 | 4 | 3M CO (MMM) | Grant/award (A): 14,301.84 @ $0 · Tax withholding (F): 268.95 @ $0 · Grant/award (A): 207,302 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1577544 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs